To Compare Relative Bioavailability of Two Clinical Formulations of Linifanib.

NCT01381341 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: linifanib

Sponsor

Abbott